Product Information

INCASSIA 0.35 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0982 per EA under NDC 65862092528. Its NADAC has been published 111 times since Oct 2, 2024.

FDA first approved this application on Sep 23, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

INCASSIA 0.35 MG TABLET

NORETHINDRONE
$0.0982per EA

Strength

.35 mg/1

NDC

65862092528

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

NORETHINDRONE

Approval Type

Generic (ANDA)

FDA Application

ANDA207304

FDA Approved

9/23/2016

TE Code

AB1

On Market Since

9/23/2016

Pharmacological Classes

Progesterone Congeners
Progestin

Price Statistics

The NADAC for INCASSIA 0.35 MG TABLET has been published 111 times since Oct 2, 2024, and over the history we have for it it has declined 7.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0982 per EA
All-time high$0.1064 (Oct 16, 2024)
All-time low$0.0691 (Nov 20, 2024)
52-week high$0.0982
52-week low$0.0849
Median price$0.0902
Average price$0.0895
Largest weekly change-22.8% (Nov 20, 2024)
Weeks tracked111
Tracking sinceOct 2, 2024

Price History

1W

0.0%

1M

+6.2%

3M

+5.4%

6M

+6.4%

1Y

+9.0%

3Y

N/A

5Y

N/A

All

-7.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of INCASSIA 0.35 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for INCASSIA 0.35 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0982 per EA (NDC 65862092528), effective Nov 11, 2026.

How has the price of INCASSIA 0.35 MG TABLET changed over time?

Over the history we have for it, the NADAC for INCASSIA 0.35 MG TABLET has declined 7.7%. It has been tracked across 111 weekly CMS publications since Oct 2, 2024.

What are the highest and lowest recorded NADAC prices for INCASSIA 0.35 MG TABLET?

Since Oct 2, 2024, the NADAC for INCASSIA 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.1064 (Oct 16, 2024), with a median of $0.0902 per EA.

Are there cheaper alternatives to INCASSIA 0.35 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERRIN 0.35 MG TABLET, is $0.0906 per EA — about 8% below INCASSIA 0.35 MG TABLET.

Who manufactures INCASSIA 0.35 MG TABLET?

INCASSIA 0.35 MG TABLET (NDC 65862092528) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.